460
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Stability and removal of dexamethasone sodium phosphate from wastewater using modified clays

, , , , , & show all
Pages 1945-1955 | Received 07 Jul 2013, Accepted 20 Jan 2014, Published online: 03 Mar 2014

References

  • Khamis M, Karaman R, Qurie M, Abbadi J, Nusseibeh S, Manassra A, Nir S. Performance of micelle–clay filters for removing pollutants and bacteria from tertiary treated wastewater. J Environ Sci Eng. 2012;1:160–168.
  • Webb S, Ternes T, Gibert M, Olejniczak K. Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett. 2003;142:157–167. doi: 10.1016/S0378-4274(03)00071-7
  • Meritxell G, Mira P, Damià B. Multi-residue analytical methods using LC-tandem MS for the determination of pharmaceuticals in environmental and wastewater samples: a review. Anal Bioanal Chem. 2006;386:941–952. doi: 10.1007/s00216-006-0586-z
  • Khamis M, Karaman R, Ayyash F, Qtait A, Deeb O, Manssra A. Efficiency of advanced membrane wastewater treatment plant towards removal of aspirin, salicylic acid, paracetamol and p-aminophenol. J Environ Sci Eng. 2011;5:121–137.
  • Tyler CR, Routledge EJ. Natural and anthropogenic environmental estrogens: the scientific basis for risk assessment. Estrogenic effects in fish in English rivers with evidence of their causation. Pure Appl Chem. 1998;70:1795–1804.
  • Johnson AC, Belfroid A, Di Corcia A. Estimating steroid estrogens inputs into activated sludge treatment works and observations on their removal from the effluent. Sci Total Environ. 2000;256:163–173. doi: 10.1016/S0048-9697(00)00481-2
  • Johnson AC, Sumpter JP. Removal of endocrine disrupting chemicals in activated sludge treatment works. Environ Sci Technol. 2002;35:4697–4703. doi: 10.1021/es010171j
  • Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998;32:3245–3260. doi: 10.1016/S0043-1354(98)00099-2
  • Jones OAH, Voulvoulis N, Lester JN. Human pharmaceuticals in wastewater treatment processes. Crit Rev Environ Sci Technol. 2005;35:401–427. doi: 10.1080/10643380590956966
  • Hirsch R, Ternes TA, Haberer K, Kratz KL. Determination of beta blockers and b-sympathomimetics in the aquatic environment. Vom Wasser. 1996;87:263–274.
  • Bendz D, Paxéus NA, Ginn TR, Loge FJ. Occurrence and fate of pharmaceutically active compounds in the environment, a case study. J Hazard Mater. 2005;122:195–204. doi: 10.1016/j.jhazmat.2005.03.012
  • Ohlenbusch G, Kumke MU, Frimmel FH. Sorption of phenols to dissolved organic matter investigated by solid phase micro extraction. Sci Total Environ. 2000;253:63–74. doi: 10.1016/S0048-9697(00)00376-4
  • Goodman-Hilman A, Rall T, Nier A, Taylor P. The pharmacological basis of therapeutics. New York: McGraw-Hill; 1996.
  • Schepers A, Pires Nuno MM, Eefting D, de Vries MR, van Bockel JH, Quax PHA. Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice. J Vasc Surg. 2006;43:809–815. doi: 10.1016/j.jvs.2005.11.019
  • Muller DW, Golomb G, Gordon D, Levy RJ. Site-specific dexamethasone delivery for the prevention of neointimal thickening after vascular stent placement. Coron Artery Dis. 1994;5:435–442. doi: 10.1097/00019501-199405000-00010
  • Strecker EP, Gabelmann A, Boos I, Lucas C, Xu Z, Haberstroh J, Freudenberg N, Stricker H, Langer M, Betz E. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc Intervent Radiol. 1998;21:487–496. doi: 10.1007/s002709900309
  • Hoffmann R, Langenberg R, Radke P, Franke A, Blindt R, Ortlepp J, Popma JJ, Weber C, Hanrath P. Evaluation of a high-dose dexamethasone-eluting stent. Am J Cardiol. 2004;94:193–195. doi: 10.1016/j.amjcard.2004.03.061
  • British Pharmacopoeia Commission. British Pharmacopeia. Revised edition. London: British Pharmacopoeia Commission; 2007. Available from: http://en.wikipedia.org/wiki/European_Commission.
  • Martindale: The Extra Pharmacopoeia. 30th ed. London: Pharmaceuticals Press; 1993. p. 728. Available from: http://en.wikipedia.org/wiki/European_Commission
  • Mishael YG, Undabeyita T, Rytwo G, Papahadjopoulos-Sternberg B, Rubin B, Nir S. Sulfometuron adsorption via alkylammonium cations adsorption as monomers and micelles on montmorillonite. J Agri Food Chem. 2002;50:2856–2863. doi: 10.1021/jf011496m
  • Polubesova T, Nir S, Zadaka D, Rabinovitz O, Serban C, Groisman L, Rubin B. Water purification of organic pollutants by optimized micelle-clay systems. Environ Sci Technol. 2005;39:2369–2384. doi: 10.1021/es049251o
  • Polubesova T, Zadaka D, Groisman L, Nir S. Water remediation by micelle–clay system: case study for tetracycline and sulfonamide antibiotics. Water Res. 2006;40: 2369–2374. doi: 10.1016/j.watres.2006.04.008
  • Zadaka D, Mishael YG, Polubesova T, Serban C, Nir S. Modified silicates and porous glass as adsorbents for removal of organic pollutants from water and comparison activated carbons. Appl Clay Sci. 2007;36:174–181. doi: 10.1016/j.clay.2006.04.012
  • Karaman R, Khamis M, Quried M, Halabieh R, Makharzeh I, Nasser A, Manassra A, Abbadi J, Qtait F, Bufo S, Nir S. Removal of diclofenac potassium from wastewater using clay-micelle complex. Environ Technol. 2012;33: 1279–1287. doi: 10.1080/09593330.2011.619582
  • Khalaf S, Al-Rimawi F, Khamis M, Zimmerman D, Shuali U, Nir S, Scrano L, Bufo SA, Karaman R. Efficiency of advanced wastewater treatment plant system and laboratory-scale micelle–clay filtration for the removal of ibuprofen residues. J Environ Sci Health B. 2013;48:814–821. doi: 10.1080/03601234.2013.781372
  • American Public Health Association (APHA). Standard methods for the examination of water and wastewater. 19th ed. Washington, DC: APHA; 1995.
  • American Public Health Association (APHA). Standard methods for the examination of water and wastewater. 21th ed. Washington, DC: APHA; 2005.
  • Dakiky M, Khamis M, Manasra A, Mereb M. Selective adsorption of chromium (VI) in industrial waste water using low cost abundantly available adsorbents. Adv Environ Res. 2002;6:533–540. doi: 10.1016/S1093-0191(01)00079-X
  • Chen Q, Zielinski D, Chen J, Koski A, Werst D, Nowak S. A validated, stability-indicating HPLC method for the determination of dexamethasone related substances on dexamethasone-coated drug-eluting stents. J Pharm Biomed Anal. 2008;48:732–738. doi: 10.1016/j.jpba.2008.07.010
  • Tomlinson ES, Maggs J, Park BK, Back DJ. Dexamethasone metabolites in vitro: species differences. J Steroid Biochem Mol Biol. 1997;4:62–68.
  • Andreottola G, Bonomo L, Pollice A. Comparison of batch completely mixed and column tests for the evaluation of phenol mobility in natural soils. Environ Technol. 1997;18:1037–1044. doi: 10.1080/09593331808616623
  • Qurie M, Khamis M, Malek F, Nir S, Bufo SA, Abbadi J, Scrano L, Karaman R. Stability and removal of naproxen and its metabolite by advanced membrane wastewater treatment plant and micelle–clay complex. CLEAN Soil Air Water. 2013; online. 10.1002/clen.201300179.
  • Wibulswas R, White DA, Rautiu R. Removal of humic substances from water by alumina-based pillared clays. Environ Technol. 1998;19:627–632. doi: 10.1080/09593331908616719
  • Cheknane B, Baudu M, Basly J-Ph, Bouras O. A desorption of basic dyes in single and mixture systems on granular inorganic–organic pillared clays. Environ Technol. 2010;31:815–822. doi: 10.1080/09593331003667758
  • Chudoba P, Pannier M. Use of powdered clay to upgrade activated sludge process. Environ Technol. 1994;15: 863–870. doi: 10.1080/09593339409385493
  • Wu F-C, Tseng R-L, Juang R-S. Kinetics of color removal by adsorption from water using activated clay. Environ Technol. 2001;22:721–729. doi: 10.1080/09593332208618235

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.